Pascal Fischer

[Pascal Fischer @PascalFLDI]

and obesity management, may increase the risk of developing gastroesophageal reflux disease (GERD) and its complications compared to sodium–glucose cotransporter-2 (SGLT-2) inhibitors (such as Brenzavvy™, Invokana®).
https://t.co/ayDxOBLiNg
#research
#type2diabetes
#obesity

[Pascal Fischer @PascalFLDI]

A recent population-based cohort study, led by @LaurentAzoulay0 from the Lady Davis Institute for Medical Research (LDI), shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which include Ozempic®, Rybelsus® and other widely- prescribed drugs for type 2 diabetes

[JGH Foundation | Fondation HGJ @HGJF_JGHF]

The donor-supported BioPortal gathers patient data that can be used to identify the specific genetic and molecular changes that drive disease. Read more in @themontrealer: https://t.co/qOSxkC0AwA

#JGHFoundation #TomorrowsAreMadeHere

[JGH Foundation | Fondation HGJ @HGJF_JGHF]

Le BioPortal, financé en partie par les donateurs, regroupe des données de patients pouvant servir à repérer les changements génétiques et moléculaires à l’origine des maladies. En savoir plus : https://t.co/qOSxkC0AwA

#FondationHGJ #LesLendemainsPrennentVieIci

[JGH Foundation | Fondation HGJ @HGJF_JGHF]

La Dre S. Wong, chirurgienne du cancer du sein à l’HGJ, voit les innovations changer des vies. Les outils comme MOLLI®, acquis grâce aux donateurs, transforment la chirurgie pour les patients.

Voyez l’impact :https://t.co/OjKyni7j2p

#FondationHGJ #LesLendemainsPrennentVieIci

[JGH Foundation | Fondation HGJ @HGJF_JGHF]

As a breast cancer surgeon at the JGH, Dr. Stephanie Wong sees how innovation changes lives. Tools like MOLLI® – made possible by donors – are transforming surgery for her patients.

Discover the impact: https://t.co/YpfBBowiWl

#JGHFoundation #TomorrowsAreMadeHere

[Pascal Fischer @PascalFLDI]

Le département d’oncologie de l’Université McGill et l’Institut Lady Davis de recherches médicales (@LDI_ILD) recherchent un(e) professeur(e) adjoint(e) à temps plein dans le domaine de la biologie fondamentale du cancer. https://t.co/wWAAUVjcee… #academicstaff #Recherche

[Pascal Fischer @PascalFLDI]

The McGill University Department of Oncology and the Lady Davis Institute for Medical Research (@LDI_ILD) in Montreal, Canada, are looking for a full-time Assistant Professor (Research) in the area of Fundamental Cancer Biology https://t.co/vONstvXkPO…#academicstaff #research

[Pascal Fischer @PascalFLDI]

Le département d’oncologie de l’Université McGill et l’Institut Lady Davis de recherches médicales (@LDI_ILD) recherchent un(e) professeur(e) adjoint(e) à temps plein dans le domaine de la biologie fondamentale du cancer.
https://t.co/8gYpPQ6V8i
#academicstaff
#Recherche

[Pascal Fischer @PascalFLDI]

The McGill University Department of Oncology and the Lady Davis Institute for Medical Research (@LDI_ILD) in Montreal, Canada, are looking for a full-time Assistant Professor (Research) in the area of Fundamental Cancer Biology.
https://t.co/vmaRB8lPT1
#academicstaff
#research

[McGill University @mcgillu]

Une étude dirigée par McGill montre que la kétamine, avec psychothérapie et un cadre de traitement favorable, offre un soulagement durable de la dépression sévère. Le « modèle de Montréal » pourrait révolutionner son usage en hôpital.

En savoir plus : https://t.co/xs1u57i2rL

[McGill University @mcgillu]

A McGill-led study shows ketamine combined with psychotherapy and supportive treatment environments offers longer-lasting relief for severe depression. The ‘Montreal Model’ could change how ketamine treatments are delivered in hospitals.

Learn more: https://t.co/vkWsH674j0

[McGill Medicine and Health Sciences @McGillMed]

An ecosystem for AI collaboration ~ McGill Collaborative for AI and Society (McCAIS), co-led by Family Med’s Samira Abbasgholizadeh-Rahimi, wants to ensure positive AI use by bringing together experts with different skillsets.
🔗 https://t.co/yHN4H1UKuS

[MI4 @MI4Innovates]

Happening June 29 at 2:00 pm - World Scleroderma Day live with the research team at McGill University! 🔬
Video by @sclerodermacan 👇
https://t.co/IUm1rYajEx

[McGill University @mcgillu]

Des experts en médecine de famille de McGill (@McGillFamMed) pilotent la première politique québécoise sur l'Alzheimer 🧠 Dr Howard Bergman et Dre Isabelle Vedel présentent des stratégies pour prévenir la maladie et améliorer l’accès aux soins.

➡️ https://t.co/0GqXWR7WEs

[McGill Medicine and Health Sciences @McGillMed]

Clinical research on psychedelics for mental health gets a boost from new study
🔗 https://t.co/PuJYHUX8lx
~~~
La recherche clinique sur l’usage des psychédéliques en santé mentale repensée grâce à une nouvelle étude
🔗 https://t.co/FsL4dFY5CN

[McGill Media Relations @McGilluMedia]

As psychedelics gain traction as potential treatments for mental health disorders, an international study co-led by @mcgillu researchers stands to improve the rigour and reliability of clinical research. https://t.co/DSaGRuG4x8

[Research Institute of the MUHC (The Institute) @RIMUHC1]

🧠Une étude révèle de grandes inégalités dans les soins aux personnes atteintes de #démence au QC, selon le quartier — malgré le système de santé universel.

📊Une première au QC, l’étude a guidé la toute première politique visant à réduire ces écarts.

🔗https://t.co/8Rx4gVMafC

[Omotayo Olaoye @OlaoyeOmotayo]

Always a pleasure to share my PhD journey through the lens of my identity and lived experience.

Thank you so much for this feature @McGillMed.

[Front Line Genomics @FLGenomics]

We’re excited to hear from @SatoshiYoshiji (Assistant Professor, @mcgillu) at The Festival of Genomics and Biodata in Boston next month. Satoshi will be giving insights into #proteogenomic analysis. Register now: https://t.co/sKbfJ0guL1 #FOGBoston